Inventor · disambiguated record
Roberto Costante
Also filed as: COSTANTE ROBERTO
3 granted patents·9 pending applications·7 citations·filing 2019–2024
58Inventor score
Files withJANSSEN BIOTECH INC5MARIANA ONCOLOGY INC4MERCK SHARP & DOHME LLC2JANSSEN PHARMACEUTICA NV1
Top patents by PatentIndex Score
12 records- 0185US11530244B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Dec 20, 2022·6 cites·15 claims
- 0282US12018057B2Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2021·Granted Jun 25, 2024·1 cites·10 claims
- 0372US2024150405A1Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0472US2024383954A1Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0569US12012468B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2022·Granted Jun 18, 2024·0 cites·15 claims
- 0665US2025186541A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0763US2024279281A1Peptide Inhibitors of Interleukin-23 ReceptorJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0861US2025011368A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0961US2025049970A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 1060US2025034210A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 1158US2024352073A1Bicyclic peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1257US2024409598A1Peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roberto Costante files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →